C
cannabis use
Lifestyle & BehavioralBehavior / exposureriskmodifiable
15
evidence score
Also known as: cannabis, marijuana
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 8.5meta-analyses: 0trials: 6genetic: 0MR bonus:
References (6)
0 meta-analyses / systematic reviews- Myocardical Infarction in Young Adults: Revisiting Risk Factors and Atherothrombotic Pathways. — Medicina (Kaunas, Lithuania) 2025 · PMID 41011006
- Cannabis use and atherosclerotic cardiovascular disease: a Mendelian randomization study. — BMC cardiovascular disorders 2023 · PMID 38093188
- Risk factors profile of young and older patients with myocardial infarction — Cardiovascular Research 2021 · PMID 34358302
- Cannabis Use and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study — Frontiers in Cardiovascular Medicine 2021 · PMID 34409073
- Cannabis and Myocardial Infarction: Risk Factors and Pathogenetic Insights. — PubMed 2017 · PMID 30294730
- Acute risk factors for myocardial infarction. — International journal of cardiology 2006 · PMID 16860887
Clinical trials (3)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT06588972 | Analgesic Effects of a Treatment With Cannabis Sativa Extract in Patients With Knee Osteoarthritis - CANOA (Cannabis for Osteoarthritis) | COMPLETED | INTERVENTIONAL | Medium Chain Triglyceride solution, Cannabis Sativa |
| NCT05184478 | A Pilot Randomized Placebo-controlled Crossover Trial of Medicinal Cannabis (MC) in Adolescents with Tourette Syndrome (TS) | COMPLETED | INTERVENTIONAL | Medicinal cannabis (MC): THC 10mg/mL : CBD 15mg/mL, manufactured by Cann Group Ltd., Placebo |
| NCT04911127 | Randomized, Double Blind, Placebo-Controlled Trial to Evaluate the Safety and Tolerability of Cannabidiol (CBD) in Moderate to Severe Rheumatoid Arthritis | COMPLETED | INTERVENTIONAL | 200mg Cannabidiol by capsules twice daily, 400mg Cannabidiol by capsules twice daily, Placebo capsules |
Genetic associations (0)
None linked.